TRICHERES PHARMA
InactiveInactive; last annual accounts for fiscal year 2025. Dissolved without liquidation on 25-02-2026.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 03-12-2025, 59 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
59 d early
2024
2 d early
2023
23 d late
2022
56 d late
2021
16 d late
2020
2 d early
2019
11 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€716
2024 · €-1k
2019: €23k
2020: €-2k▼ -109% vs 2019
2021: €104k▲ +5071% vs 2020
2022: €662k▲ +535% vs 2021highest in 7 years
2023: €-510k▼ -177% vs 2022lowest in 7 years
2024: €-1k▲ +99.8% vs 2023
2025: €716▲ +156% vs 2024
2019 → 2025
Working capital
€295k▼ 12.9%
2023 · €338k
2019: €308k
2020: €279k▼ -9.3% vs 2019
2021: €-714k▼ -356% vs 2020lowest value
2022: €-52k▲ +92.8% vs 2021
2023: €338k▲ +755% vs 2022highest value
2025: €295k
2019 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-243k-€419k€-91k€-92k▼ 1.4%€-92k▲ 0.8%
2021: €-243klowest in 5 years
2022: €419k▲ +273% vs 2021highest in 5 years
2023: €-91k▼ -122% vs 2022
2024: €-92k▼ -1.4% vs 2023
2025: €-92k▲ +0.8% vs 2024
Operating result€104k-€162k▲ 55.5%€-510k€-1k▲ 99.8%€850
2021: €104k
2022: €162k▲ +55.5% vs 2021highest in 5 years
2023: €-510k▼ -415% vs 2022lowest in 5 years
2024: €-1k▲ +99.8% vs 2023
2025: €850▲ +170% vs 2024
Net result€104k-€662k▲ 535%€-510k€-1k▲ 99.8%€716
2021: €104k
2022: €662k▲ +535% vs 2021highest in 5 years
2023: €-510k▼ -177% vs 2022lowest in 5 years
2024: €-1k▲ +99.8% vs 2023
2025: €716▲ +156% vs 2024
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €850 after a loss of €1k in 2024.
Key figures and ratios
Solvency
-31.0%▼
2024 · -31.0%
Debt to equity
-4.22▲
2024 · -4.22
ROA
0.2%▲
2024 · -0.4%
Debt
€387k▼
2024 · €390k
Debt ≤ 1 year
€582
Debt > 1 year
€386k▼
2024 · €390k
A ratio outside any meaningful range has been withheld (balance sheet total €295k, equity €-92k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 30 lines
Balance sheet
Code20242025
Assets
Total assets20/58€298k€295k▼
Fixed assets21/28€572-
Financial fixed assets28€572-
Current assets29/58€297k€295k▼
Amounts receivable after more than one year29€222k€222k=
Other amounts receivable291€222k€222k=
Amounts receivable within one year40/41€66k€66k▲
Trade receivables40-€567
Other amounts receivable41€66k€66k▼
Cash at bank and in hand54/58€10k€8k▼
Equity and liabilities
Total equity and liabilities10/49€298k€295k▼
Equity10/15€-92k€-92k▲
Contributions10/11€19k€19k=
Profit (loss) carried forward14€-111k€-110k▲
Amounts payable17/49€390k€387k▼
Amounts payable after more than one year17€390k€386k▼
Financial debts170/4€390k€386k▼
Amounts payable within one year42/48-€582
Taxes, remuneration and social security45-€582
Taxes450/3-€582
Income statement
Code20242025
Non-recurring operating charges66A-€572
Gross operating margin9900€-1k€1k▲
Operating profit (loss)9901€-1k€850▲
Financial charges65/66B€56€134▲
Recurring financial charges65€56€134▲
Profit (loss) for the period before taxes9903€-1k€716▲
Profit (loss) for the period9904€-1k€716▲
Profit (loss) for the period to be appropriated9905€-1k€716▲
Appropriation of the result
Profit (loss) to be appropriated9906€-111k€-110k▲
Profit (loss) brought forward from the previous period14P€-110k€-111k▼
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating charges66A | - | - | €600k | - | €572 | - |
| Gross operating margin9900 | €104k | €162k | €90k | €-1k | €1k | ▲ 217% |
| Operating profit (loss)9901 | €104k | €162k | €-510k | €-1k | €850 | ▲ 170% |
| Financial income75/76B | - | €500k | - | - | - | - |
| Recurring financial income75 | - | €500k | - | - | - | - |
| Non-recurring financial income76B | - | €500k | - | - | - | - |
| Financial charges65/66B | - | €55 | €58 | €56 | €134 | ▲ 138% |
| Recurring financial charges65 | €47 | €55 | €58 | €56 | €134 | ▲ 138% |
| Non-recurring financial charges66B | - | - | €58 | - | - | - |
| Profit (loss) for the period before taxes9903 | €104k | €662k | €-510k | €-1k | €716 | ▲ 156% |
| Profit (loss) for the period9904 | €104k | €662k | €-510k | €-1k | €716 | ▲ 156% |
| Profit (loss) for the period to be appropriated9905 | €104k | €662k | €-510k | €-1k | €716 | ▲ 156% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.27M | €2.38M | €339k | €298k | €295k | ▼ 0.9% |
| Fixed assets21/28 | €1.90M | €1.90M | €572 | €572 | - | - |
| Financial fixed assets28 | €1.90M | €1.90M | €572 | €572 | - | - |
| Current assets29/58 | €373k | €482k | €339k | €297k | €295k | ▼ 0.7% |
| Amounts receivable after more than one year29 | - | €172k | €172k | €222k | €222k | = |
| Other amounts receivable291 | - | €172k | €172k | €222k | €222k | = |
| Amounts receivable within one year40/41 | €128k | €60k | €157k | €66k | €66k | ▲ 0.7% |
| Trade receivables40 | - | €60k | €91k | - | €567 | - |
| Other amounts receivable41 | - | €2 | €66k | €66k | €66k | ▼ 0.2% |
| Cash at bank and in hand54/58 | €45k | €250k | €10k | €10k | €8k | ▼ 24.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.27M | €2.38M | €339k | €298k | €295k | ▼ 0.9% |
| Equity10/15 | €-243k | €419k | €-91k | €-92k | €-92k | ▲ 0.8% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | - | €401k | - | - | - | - |
| Distributable reserves133 | - | €401k | - | - | - | - |
| Profit (loss) carried forward14 | €-262k | - | €-110k | €-111k | €-110k | ▲ 0.6% |
| Amounts payable17/49 | €2.52M | €1.96M | €430k | €390k | €387k | ▼ 0.8% |
| Amounts payable after more than one year17 | €1.43M | €1.43M | €430k | €390k | €386k | ▼ 1.0% |
| Financial debts170/4 | - | €1.43M | €430k | €390k | €386k | ▼ 1.0% |
| Amounts payable within one year42/48 | €1.09M | €533k | €348 | - | €582 | - |
| Trade debts44 | €348 | €348 | €348 | - | - | - |
| Bills of exchange payable441 | - | €348 | €348 | - | - | - |
| Taxes, remuneration and social security45 | - | €23k | - | - | €582 | - |
| Taxes450/3 | - | €23k | - | - | €582 | - |
| Other amounts payable47/48 | - | €510k | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €104k | €662k | €-510k | €-1k | €716 | ▲ 156% |
| Operating cash flow (approximation) | €104k | €662k | €-510k | €-1k | €716 | ▲ 156% |
| Investment in fixed assets (approximation) | - | €0 | €1.90M | €0 | - | - |
| Change in cash | - | €205k | €-239k | €-287 | €-2k | ▼ 753% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-03
State Gazette act
Restructuring · End & cessationMerger · Dissolution · Share cancellation6 facts ▸
State Gazette act
Restructuring · End & cessation
Merger · Dissolution · Share cancellation6 facts ▸
- General meeting, 25-02-2026
- Merger, décision de fusion à prendre par l'assemblée générale des actionnaires de la société à responsabilité limitée DUVIPHAR
- Dissolution, 25-02-2026
- Share cancellation, DUVIPHAR, totalité des actions
- Approval, 2025-12
- Power of attorney, Vincent DUFRASNE
2025
03-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial
Back to profitnet €716
Net result €716 after 2 loss-making years.
29-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
23-02
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 23 days late
2023
30-06
Financial
Weakest financial yearnet €-510k
Net result drops to €-510k, the lowest in the series.
30-06
Financial
Liquidity times 1080current ratio 975.02
Current ratio from 0.90 to 975.02; short-term debt falls from €533k to €348.
28-03
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 56 days late
2022
30-06
Financial
Highest result since 2019net €662k ▲535%
Operating result €162k, net result €662k, both a record.
30-06
Financial
Equity above €200kEq €419k
2 profitable years in a row build equity to €419k.
16-02
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 16 days late
2021
30-06
Financial
Back to profitnet €104k
Net result €104k after one loss-making year.
Show earlier events
29-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
11-02
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 11 days late
2019
10-01
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
05-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
23-01
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 6 acts read
About the unread acts
Of the 6 Belgian State Gazette acts we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Structure & network
Acquisitions and mergers
1 transactionTaken over by:DUVIPHAR